Dimethyl terephthalate CAS:120-61-6

Dimethyl terephthalate

Chemical Name:Dimethyl terephthalate
CAS.NO:120-61-6
Synonyms:Dimethyl terephthalate
1,4-Benzenedicarboxylic acid, dimethyl ester
Terephthalic Acid Dimethyl Ester
DMT
dimethyl benzene-1,4-dicarboxylate
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 285.0±8.0 °C at 760 mmHg
Melting Point 140 °C
Molecular Formula C10H10O4
Molecular Weight 194.184
Flash Point 148.0±7.9 °C
 
Specification:
Appearance:White Chunks 
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Pigment yellow 155 Intermediate



We are professional Dimethyl terephthalate manufacturer and dimethyl benzene-1,4-dicarboxylate supplier in China, We offer quality Dimethyl terephthalate you can fully trust, also we have India factory and producer of Terephthalic Acid Dimethyl Ester,Pls send inquiry of dimethyl benzene-1,4-dicarboxylate CAS:120-61-6 to info@nbinno.com if you have any interests, thank you!


Related News: The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions.9,9,10-triphenyl-9,10-dihydroacridine In the process of fine chemical industry transfer, intermediates are a very important category, and they are also the main link for China to undertake transfers.3-t-Butoxycarbonylphenylboronic acid CAS:220210-56-0 The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers.2-Bromo-5-fluorobenzotrifluoride This is how an API becomes a medicine.In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .